Morningside Ventures / Sofinnova Partners / Scottish Investment Bank / Bioenvision Inc. / Dow Jones and Company / Genzyme / Alida Capital International / NuCana BioMed Ltd . / Seattle Genetics Inc. / Eli Lilly & Co . / Sofinnova Ventures / /
Continent
Europe / /
Country
United Kingdom / /
Currency
USD / / /
Event
Funding / M&A / IPO / /
Facility
Cardiff University / /
IndustryTerm
pharmaceutical industry / treatment for pediatric acute lymphoblastic leukemia / cancer therapies / /
MedicalCondition
ovarian cancer / pediatric acute lymphoblastic leukemia / non small-cell lung cancer / molecularly targeted cancer / biliary cancer / pancreatic cancer / rapidly dividing cancer / Cancers / tumor / squamous cell carcinoma / cancer / tumors / disease / solid tumor / diseases / stable disease / /
MedicalTreatment
chemotherapy / chemotherapies / bypass / cancer therapies / /
Organization
Cardiff University / /
Person
Brian Gormley April / Gerald Chan / Hugh Griffith / James Healy / Chris McGuigan / Brian Gormley / /
Position
co-founder and Chief Executive / co-founder and chairman / /
Sofinnova Ventures Leads $57M Financing for NuCana BioMed Brian Gormley April 10, 2014 Sofinnova Ventures is leading a $57 million financing for NuCana BioMed Ltd ., which is developing better versions of existing chemot